URS→FAT/SAT→IQ/OQ/PQ: Who Authors, Who Approves


Published on 28/11/2025

URS→FAT/SAT→IQ/OQ/PQ: Who Authors, Who Approves

Introduction to Validation in Pharmaceuticals

In the pharmaceutical industry, validation is a critical process mandated by regulatory bodies such as the FDA, EMA, and MHRA. It involves a series of documented activities designed to ensure that systems, processes, and equipment consistently produce products that meet established quality specifications. This article will outline the systematic approach to validation, focusing on the interrelationships between User Requirement Specifications (URS), Factory Acceptance Testing (FAT), Site Acceptance Testing (SAT), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).

Understanding User Requirement Specifications (URS)

The User Requirement Specification (URS) serves as the foundation for all subsequent validation activities. It is essential to involve all relevant stakeholders early in the development of the URS.

  • Stakeholder Engagement: This involves clinical operations, regulatory affairs, and quality assurance teams, ensuring that all requirements are captured accurately.
  • Define Scope: Define the objectives, functionalities, and performance criteria for the system or process being validated.
  • Document Expectations: Clearly outline what is expected in terms of system performance, expected outputs, and compliance with regulatory standards.

Transitioning from URS to Factory Acceptance Testing (FAT)

Once the URS has been finalized, the next logical step is to conduct the Factory Acceptance Testing (FAT). This phase is crucial for verifying that equipment and systems meet the URS before shipping to the production site.

  • FAT Protocol Development: A detailed FAT protocol must be developed, including test cases that cover all aspects of the URS.
  • Execution: Execute the FAT in the vendor’s facility, ensuring the presence of the Quality Assurance team to witness critical tests.
  • Documentation: Thoroughly document all results, discrepancies, and corrective actions identified during FAT. Ensure that all observations are categorized, justified, and resolved before shipping.

Site Acceptance Testing (SAT) and Its Significance

After the equipment arrives, Site Acceptance Testing (SAT) is executed. The SAT ensures that the system operates as intended in the production environment.

  • Preparing the SAT Protocol: Develop a comprehensive SAT protocol that addresses the specific conditions of the installation site.
  • Conducting SAT: Involve technical experts and QA personnel to evaluate the integration of the equipment within the existing infrastructure.
  • Validation of Environment: Verify that environmental conditions such as temperature and humidity meet the specifications outlined in the URS.

Installation Qualification (IQ): Ensuring Proper Setup

The Installation Qualification (IQ) validates that the equipment or system has been installed correctly and adheres to URS conditions. It is a systematic procedure that serves to confirm the installed state of the device.

  • Creating an IQ Checklist: Develop a checklist that outlines all components, settings, and configurations that must be verified post-installation.
  • Performing Equipment Checks: Carry out checks on equipment such as electrical connections, calibration settings, and software installations.
  • Documentation and Reporting: Ensure detailed documentation of the installation process, highlighting any deviations or modifications made during installation.

Operational Qualification (OQ): Validating Functionality

Operational Qualification (OQ) determines whether the equipment or system functions as intended across the specified operating range. This stage assesses the operational functionality of the equipment under normal and worst-case conditions.

  • OQ Test Development: Prepare OQ tests that include operability under various scenarios. Focus on critical functions, including response times and operational limits.
  • Execution of OQ: Conduct tests and validate against specifications. Involve cross-functional teams to provide insights into potential operational failures.
  • Analysis and Reporting: Analyze the OQ results to confirm all operational parameters are itialized correctly.

Performance Qualification (PQ): Ensuring Quality Output

Performance Qualification (PQ) focuses on how effectively a system or equipment produces a product that meets predefined quality specifications under normal operating conditions.

  • Quality Specifications: Review critical quality attributes (CQAs) that must be assessed during the PQ tests, ensuring every product is within the acceptable limits.
  • Conducting PQ: Execute tests simulating routine production conditions. Evaluate a statistically significant number of batches to verify the system’s reliability and robustness.
  • Final Documentation: Document all findings thoroughly, including any product deviations and the corresponding actions taken to address them.

Validation Deliverables and Ownership

Throughout each phase of validation, deliverables must be clearly defined. Ownership for these documents often resides within different departments, and clarity in this aspect is paramount.

  • Document Control: Ensure that all validation deliverables are controlled and accessible, adhering to 21 CFR Part 11 guidelines.
  • Responsibility Assignment: Specify who is responsible for drafting, reviewing, and approving each validation document—this could include Quality Assurance, Engineering, and Operations personnel.
  • Stakeholder Review: Implement a review system where appropriate stakeholders such as Regulatory Affairs and Technical Operations provide feedback during validation outcomes.

Supplier Qualification and Quality Agreement Clauses

Supplier qualification is critical for ensuring that external vendors meet necessary compliance and quality standards, particularly for suppliers involved in manufacturing or testing.

  • Understanding Quality Agreements: Detail the obligations of the supplier in a quality agreement, specifying clauses that address quality, regulatory compliance, and auditing processes.
  • Vendor Audits: Establish a routine auditing process for suppliers to ensure continuing compliance with quality standards. Include risk assessments as part of the vendor audit process.
  • Ongoing Review: Implement ongoing monitoring and review protocols to track supplier performance and compliance with quality specifications.

Integrating ICH Q10 Principles in Validation

Incorporating the principles outlined in ICH Q10 (Pharmaceutical Quality System) enhances the validation process by driving an integrated approach to quality management.

  • Defining Quality Management System (QMS): Ensure that systems are established to manage quality from development through to commercialization while adhering to the lifecycle model.
  • Continuous Improvement: Foster an environment where quality improvement initiatives are supported and encouraged, including CAPA (Corrective Action and Preventive Action) systems.
  • Risk-Based Approaches: Implement a risk-based approach to validation that aligns with ICH Q10 and promotes efficient resource allocation while maintaining compliance.

Conclusion: A Holistic Approach to Validation

Understanding the essential phases of validation—from URS to PQ—is critical for the operational success of pharmaceutical processes. A robust validation strategy should integrate quality agreements, supplier qualifications, and an understanding of ICH Q10 principles.

By ensuring that validation activities are well-documented and that responsibilities for validation deliverables are clearly defined, organizations can mitigate risks and enhance product quality, ultimately leading to successful regulatory compliance and operational excellence.

The landscape of the pharmaceutical industry demands stringent adherence to regulations and continuous improvements in validation methodologies. Stakeholders must remain vigilant and engaged throughout the process to ensure the delivery of safe and effective medical products.